Definium Therapeutics is a late-stage clinical biopharmaceutical company focused on developing accessible treatments for psychiatric disorders using psychedelics. Our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics. Our lead product candidate, lysergide tartrate, is being developed for generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our pipeline also includes DT402, targeting core symptoms of autism spectrum disorder. We aim to change the trajectory of mental health care by addressing the underlying causes of psychiatric and neurological disorders. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX. We are moving psychiatry forward into a boundless future.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director